Diaceutics PLC

We provide the world’s leading pharma and biotech companies with solutions for #PrecisionMedicine commercial strategies. #BetterTestingBetterTreatment

[Diaceutics PLC @Diaceutics]

It was a pleasure to bring together stakeholders from across the precision medicine industry last week for The Precision Medicine Practice Gaps Economic, Policy, and Operational Solutions Global Summit. Watch the full recording now on DXRX:
https://t.co/IajILbgD7p

[DXRX: The Diagnostic Network® @DXRX_LabNetwork]

An exciting update for our #podcast listeners! Our podcast is now available on Spotify and Apple Podcasts 🎙️

Don't miss out on our newest episode, 'Oncogenic Fusion detection and reporting in NSCLC and solid tumors: from clinic to lab'

Listen now - https://t.co/qPgaKYoHPo

[DXRX: The Diagnostic Network® @DXRX_LabNetwork]

Episode 5 of the Better testing, Better Treatment podcast is now LIVE!

In episode 5, Dr James Solomon & @DrAshish_Saxena delve into the practical considerations for oncogenic fusion detection, reporting & guide treatments.

https://t.co/5sWOc0f3iP

#OncogenicFusions

[Xtalks Webinars @Xtalks]

📢 Join @Diaceutics for an upcoming webinar to discover how to optimize precision medicine and targeted therapies! ➡️ Learn about market trends, strategic insights, and cost-efficient approaches for successful commercialization: https://t.co/VmcBSnVyef

#PrecisionMedicine

[Diaceutics PLC @Diaceutics]

New webinar series! Led by Diaceutics’ in-house precision medicine experts to provide valuable insights to overcome challenges in the PM market and drive commercial success for your targeted therapy. Join us for our first webinar on Thursday, September 5, 2024, from 1-2pm EDT.

[DXRX: The Diagnostic Network® @DXRX_LabNetwork]

Professor Zannoni shares his experience of European collaboration on endometrial cancer testing, the impact of this collaboration on the scientific lab community and working with Diaceutics on the project.

Read the report now - https://t.co/0LRZfXP7Ix

#Endometrialcancer

[DXRX: The Diagnostic Network® @DXRX_LabNetwork]

Calling all lab experts 🧬

Join us TODAY for our exciting Precision Medicine in Oncology virtual event.

First talk is at 11am CEST with Prof. Dr. Klaus Pantel.

Don't miss out! https://t.co/93ok5VE5H4

#oncology #pathtwitter #pathology @Labroots

[Diaceutics PLC @Diaceutics]

Not long until the next Diaceutics virtual event, Precision medicine in oncology!

Attendees will gain a deeper understanding of relevant topics such as liquid biopsy, MRD , early-stage cancer, genomic profiling, and artificial intelligence tools.

https://t.co/l568j6Iww8

[Diaceutics PLC @Diaceutics]

5 day countdown! 🕔

Time is running out to sign up to our Precision Medicine in Oncology virtual event held on the 19th June. Register now: https://t.co/2hhMQ469Ez

Want to stay up to date with the latest DXRX news & events? Join the DXRX community and follow @DXRX_LabNetwork

[DXRX: The Diagnostic Network® @DXRX_LabNetwork]

Not long to go until the Precision medicine in oncology event!

Professor @clare__turnbull will be presenting ‘The role of comprehensive genomic profiling in precision oncology’. Check out her exclusive insights on the event and presentation!

Sign up now!
https://t.co/QsHQMVHT0v

[Diaceutics PLC @Diaceutics]

Sign up for event 9 in the 'Precision medicine in solid tumors event'. This session will review updates and challenges associated with assessment of thyroid FNAs, focusing on recognizing cytomorphology patters of thyroid FNA.

Don’t miss out!

https://t.co/wCrekkjY8L

[Diaceutics PLC @Diaceutics]

Our team had an amazing time in Chicago for ASCO 2024, meeting both new and existing customers and learning about the latest findings in oncology research. Read our latest blog where we share our key highlights from ASCO. Read blog here: https://t.co/1ZiYxy0iAm

#ASCO2024 #ASCO24

[Diaceutics PLC @Diaceutics]

ASCO daily highlights: Monday 3rd June

Our team have had an amazing week at ASCO meeting with both new and existing customers and learning about the latest advancements in the field of oncology. Read our highlights here: https://t.co/VsP3NzPJu3

#ASCO2024 #ASCO24

[Diaceutics PLC @Diaceutics]

New blog! Navigating the New Amendments to the EU In Vitro Devices Regulation (IVDR). In our latest blog, Dave Smart, Snr Dir. of Analytics at Diaceutics shares key highlights and provides insights into these significant changes and their implications. https://t.co/zoWsGiYA6m

[Diaceutics PLC @Diaceutics]

ASCO daily highlights: Sunday 2nd June

Read our key highlights from day 3 at ASCO. Stay tuned to our LinkedIn page where we will be sharing our daily highlights throughout the conference.
Read here: https://t.co/GPHLMAMTAI

#ASCO2024 #ASCO24

[Diaceutics PLC @Diaceutics]

We are delighted to have our research accepted for poster presentation at ASCO this year. Don’t miss Ying Liu, one of our abstract authors, who will be presenting this research during the morning session today at ASCO, 9:00 am to 12:00 pm, Hall A.

#ASCO2024 #ASCO24

[Diaceutics PLC @Diaceutics]

ASCO daily highlights: Saturday 1st June

Read our key highlights from day 2 at ASCO. Stay tuned to our LinkedIn page where we will be sharing our precision medicine expert daily highlights throughout the conference. Read here: https://t.co/ZOGccnzUzD

#ASCO2024 #ASCO24

[Diaceutics PLC @Diaceutics]

ASCO daily highlights

Our team on the ground share some key highlights from an exciting first day at ASCO 2024. Follow us for more daily highlights throughout the conference!

Read highlights here: https://t.co/URF675vv88

#ASCO24 #ASCO2024

[Diaceutics PLC @Diaceutics]

We are delighted to have two of our abstracts accepted for poster presentation and online publication at this year’s ASCO. Read more here: https://t.co/yVPl0LsFx5. Schedule a meeting with one of our solution experts at ASCO using the link below:
https://t.co/qKhmIvhCnH
#ASCO2024

[Diaceutics PLC @Diaceutics]

DXRX Signal delivers an actionable alert of a testing behavior, allowing you to engage a physician during the treatment decision timeframe, maximizing effectiveness of your sales and marketing activities. Meet our team at ASCO to learn more: https://t.co/RVpo3oCZSP
#ASCO2024

[Diaceutics PLC @Diaceutics]

Only 3 days to go until we will be in Chicago for ASCO . Schedule a meeting with one of our experts to learn more about how Diaceutics are uniquely positioned to help you achieve commercialization success for your precision medicine.
Link: https://t.co/s1jUsEkQsE

[Diaceutics PLC @Diaceutics]

Don't miss out and join us tomorrow for event 8 in the ‘Precision medicine in oncology’ series surrounding the history of CAR-T, research, scientific evidence, and approval. Two international experts will share their experience of the use of CAR-T.

https://t.co/iSQEBFL1cd